Table 3.
1 | The cellular and molecular mechanisms and the potential interplay of COX-2 derived PGs in control of energy metabolism and the development of obesity and insulin resistance. |
2 | The detailed mechanisms regarding the role of PGs and their receptors in the development of these COX-2 mediated phenomenon. |
3 | The therapeutive strategy to develop COX-2 targeting compounds which could boost energy expenditure without trigger COX-2-mediated inflammation |
4 | To dissect the role of COX-2 dependent and independent adaptive thermogenesis and their impact on energy homeostasis |
5 | Clinical application of selective COX-2 activator in prevention and treatment of NAFLD |